"Designing Growth Strategies is in our DNA"

U.S. Heparin Market Size, Share, Analysis, By Product (Unfractionated Heparin (UFH) and Low Molecular Weight Heparin (LMWH)), By Source (Bovine and Porcine), By Application (Deep Vein Thrombosis & Pulmonary Embolism, Atrial Fibrillation, Heart Attacks, Stroke, and Others), By Route of Administration (Intravenous Infusion and Subcutaneous Injection), and By End-user (Hospitals & ASCs, Clinics, and Others), and Country Forecast, 2024-2032

Last Updated: February 17, 2025 | Format: PDF | Report ID: FBI108746

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions & Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Key Cardiovascular Diseases in the U.S.
    2. Blood Clots: Stats & Facts
    3. Overview of Technological Advancements in Heparin
    4. New Product Launches, By Key Players
    5. Key Industry Development: Mergers, Acquisitions, and Partnerships
    6. Regulatory Scenario
    7. Reimbursement Scenario
    8. Impact of COVID-19 on the Market
  5. U.S. Heparin Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Product
      1. Unfractionated Heparin (UFH)
      2. Low Molecular Weight Heparin (LMWH)
    2. Market Analysis, Insights and Forecast – By Source
      1. Bovine
      2. Porcine
    3. Market Analysis, Insights and Forecast – By Application
      1. Deep Vein Thrombosis & Pulmonary Embolism
      2. Atrial Fibrillation
      3. Heart Attacks
      4. Stroke
      5. Others
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Intravenous Infusion
      2. Subcutaneous Injection
    5. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & ASCs
      2. Clinics
      3. Others
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2023)
    2. Company Profiles
      1. Pfizer Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. Fresenius SE & Co. KGaA
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. B. Braun SE
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Sagent Pharmaceuticals
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. Mylan N.V.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. Baxter
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. Amphastar Pharmaceuticals, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      8. Scientific Protein Laboratories
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
Read Less

Figure 1:  U.S. Heparin Market Revenue Breakdown (USD billion, %), By Product, 2024 & 2032

Figure 2:  U.S. Heparin Market Value Share (%), by Product, 2024 & 2032

Figure 3:  U.S. Heparin Market Value Share (%), by Source, 2024 & 2032

Figure 4:  U.S. Heparin Market Value Share (%), by Application, 2024 & 2032

Figure 5:  U.S. Heparin Market Value Share (%), by Route of Administration, 2024 & 2032

Figure 6:  U.S. Heparin Market Value Share (%), by End User, 2024 & 2032

Figure 7:  U.S. Heparin Market Share (%), By Company, 2023

Table 1:  U.S. Heparin Market Revenue (USD billion) Forecast, by Product, 2019–2032

Table 2:  U.S. Heparin Market Revenue (USD billion) Forecast, by Source, 2019–2032

Table 3:  U.S. Heparin Market Revenue (USD billion) Forecast, by Application, 2019–2032

Table 4:  U.S. Heparin Market Revenue (USD billion) Forecast, by Route of Administration, 2019–2032

Table 5:  U.S. Heparin Market Revenue (USD billion) Forecast, by End User, 2019–2032

U.S. Heparin Market Size, Share and Global Industry Trend Forecast till 2032
  • 2019-2032
  • 2023
  • 2019-2022
  • 90
Consulting Services
    How will you benefit from our consulting services ?